JM

Jitender Mehto

Active Director Additional Director DIN 11102642
DIN 11102642 First appointment May 2025 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Jitender Mehto

Data last updated:

Jitender Mehto is an Additional Director at Nynorvix Services Private Limited (since 2025). The company operates in Research & Development.

DIN 11102642
Primary Designation Additional Director
Industry Research & Development
First Appointment 12 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nynorvix Services Private Limited U62090DL2024PTC440436
Additional Director12 May 20252024Active

Board colleagues of Jitender Mehto

NameDINCompanyDesignation
Ajay11022872Nynorvix Services Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Nynorvix Services Private Limited
Premium access

Shareholding and investment profile for Jitender Mehto

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jitender Mehto

Jitender Mehto currently holds 1 directorship: Nynorvix Services Private Limited (Additional Director, since 12 May 2025).

Jitender Mehto was first appointed on 12 May 2025 as Additional Director at Nynorvix Services Private Limited.

The current boards of Jitender Mehto's companies include Ajay (Nynorvix Services Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available